The PREFER in AF study reported that diabetic patients on insulin therapy had a higher stroke risk (HR 2.19, P=0.009) than non‐diabetic patients, while those not treated with insulin had a similar risk to non‐diabetics (HR 0.93, P=0.80).380. Here, INS is linked to atrial fibrillation.